99 related articles for article (PubMed ID: 24113182)
1. Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells.
Lam CR; Tan C; Teo Z; Tay CY; Phua T; Wu YL; Cai PQ; Tan LP; Chen X; Zhu P; Tan NS
Cell Death Dis; 2013 Oct; 4(10):e848. PubMed ID: 24113182
[TBL] [Abstract][Full Text] [Related]
2. Protons sensitize epithelial cells to mesenchymal transition.
Wang M; Hada M; Saha J; Sridharan DM; Pluth JM; Cucinotta FA
PLoS One; 2012; 7(7):e41249. PubMed ID: 22844446
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological targeting of netrin-1 inhibits EMT in cancer.
Lengrand J; Pastushenko I; Vanuytven S; Song Y; Venet D; Sarate RM; Bellina M; Moers V; Boinet A; Sifrim A; Rama N; Ducarouge B; Van Herck J; Dubois C; Scozzaro S; Lemaire S; Gieskes S; Bonni S; Collin A; Braissand N; Allard J; Zindy E; Decaestecker C; Sotiriou C; Salmon I; Mehlen P; Voet T; Bernet A; Blanpain C
Nature; 2023 Aug; 620(7973):402-408. PubMed ID: 37532929
[TBL] [Abstract][Full Text] [Related]
4. Cancer cells regulate biomechanical properties of human microvascular endothelial cells.
Mierke CT
J Biol Chem; 2011 Nov; 286(46):40025-37. PubMed ID: 21940631
[TBL] [Abstract][Full Text] [Related]
5. RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M; Rodríguez-Acebes S; Blondeau J; Parent MA; Zocco M; Song Y; de Maertelaer V; Moers V; Latil M; Dubois C; Coulonval K; Impens F; Van Haver D; Dufour S; Uemura A; Sotiropoulou PA; Méndez J; Blanpain C
Nature; 2023 Apr; 616(7955):168-175. PubMed ID: 36949199
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Epithelial to Mesenchymal Transition Signaling Pathways by
Razali RA; Lokanathan Y; Yazid MD; Ansari AS; Saim AB; Hj Idrus RB
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315241
[TBL] [Abstract][Full Text] [Related]
7. The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling.
Ungefroren H; Wellner UF; Keck T; Lehnert H; Marquardt JU
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33266416
[TBL] [Abstract][Full Text] [Related]
8. TGFβ Impairs HNF1α Functional Activity in Epithelial-to-Mesenchymal Transition Interfering With the Recruitment of CBP/p300 Acetyltransferases.
Bisceglia F; Battistelli C; Noce V; Montaldo C; Zammataro A; Strippoli R; Tripodi M; Amicone L; Marchetti A
Front Pharmacol; 2019; 10():942. PubMed ID: 31543815
[TBL] [Abstract][Full Text] [Related]
9. EMT-Induced Cell-Mechanical Changes Enhance Mitotic Rounding Strength.
Hosseini K; Taubenberger A; Werner C; Fischer-Friedrich E
Adv Sci (Weinh); 2020 Oct; 7(19):2001276. PubMed ID: 33042748
[TBL] [Abstract][Full Text] [Related]
10. Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives.
Runa F; Adamian Y; Kelber JA
Cancer Cell Microenviron; 2016; 3(1):. PubMed ID: 29392163
[TBL] [Abstract][Full Text] [Related]
11. Adaptation to volumetric compression drives hepatoblastoma cells to an apoptosis-resistant and invasive phenotype.
Gong X; Ogino N; Leite MF; Chen Z; Nguyen R; Liu R; Kruglov E; Flores K; Cabral A; Mendes GMM; Ehrlich BE; Mak M
bioRxiv; 2023 Oct; ():. PubMed ID: 37873476
[TBL] [Abstract][Full Text] [Related]
12. YWHAG Deficiency Disrupts the EMT-Associated Network to Induce Oxidative Cell Death and Prevent Metastasis.
Lee JXT; Tan WR; Low ZS; Lee JQ; Chua D; Yeo WDC; See B; Vos MIG; Yasuda T; Nomura S; Cheng HS; Tan NS
Adv Sci (Weinh); 2023 Nov; 10(31):e2301714. PubMed ID: 37759388
[TBL] [Abstract][Full Text] [Related]
13. Importance of TAK-1 levels in patients with non-small cell lung carcinoma.
Sürücü P; Büyükkarabacak Y; Süllü Y; Basoğlu A
Turk Gogus Kalp Damar Cerrahisi Derg; 2022 Oct; 30(4):574-583. PubMed ID: 36605324
[TBL] [Abstract][Full Text] [Related]
14. A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).
Genenger B; Perry JR; Ashford B; Ranson M
Discov Oncol; 2022 Jun; 13(1):42. PubMed ID: 35666359
[TBL] [Abstract][Full Text] [Related]
15. Redox signaling at the crossroads of human health and disease.
Zuo J; Zhang Z; Luo M; Zhou L; Nice EC; Zhang W; Wang C; Huang C
MedComm (2020); 2022 Jun; 3(2):e127. PubMed ID: 35386842
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox.
Hasan A; Rizvi SF; Parveen S; Pathak N; Nazir A; Mir SS
Front Oncol; 2022; 12():852424. PubMed ID: 35359388
[TBL] [Abstract][Full Text] [Related]
17. Cross-Talk between Oxidative Stress and m
Yang B; Chen Q
Oxid Med Cell Longev; 2021; 2021():6545728. PubMed ID: 34484567
[TBL] [Abstract][Full Text] [Related]
18. Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy.
Okubo R; Hasegawa T; Fukuyama K; Shiroyama T; Okada M
Front Psychiatry; 2021; 12():623684. PubMed ID: 33679481
[TBL] [Abstract][Full Text] [Related]
19. The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC).
Basak D; Uddin MN; Hancock J
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187272
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
